Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasm Metastasis × tislelizumab × Clear all

Phase

Status

Terminated 4 Completed 4 Active not recruiting 3 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Esophageal Neoplasms 7 Stomach Neoplasms 4 Nasopharyngeal Carcinoma 4 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Hodgkin Disease 2 Glioblastoma 2 Advanced Solid Tumor 2 mCRPC 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 SCLC, Extensive Stage 1 Recurrence 1 Rare Tumour 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 NSCLC 1 MSI-H Colorectal Cancer 1 Lymphoma, Follicular 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1

Interventions

trastuzumab deruxtecan 4 Cisplatin 4 toripalimab 3 pembrolizumab 3 Radiosurgery 3 Bevacizumab 3 sacituzumab govitecan 2 cemiplimab 2 Therapeutics 2 Standard of Care 2 Radiotherapy 2 Palliative Care 2 Injections 2 Gemcitabine 2 Fulvestrant 2 Fluorouracil 2 Cyclophosphamide 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vedolizumab 1 tislelizumab 1 sintilimab 1 lobaplatin 1 ivosidenib 1 irinotecan sucrosofate 1 fludarabine 1 exemestane 1 eribulin 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡